Multi-Channel Cross-Cultural Marketing

This article describes how Boehringer Ingelheim teamed up with with Univison in a ground-breaking campaign to drive awareness for Type 2 Diabetes through story-line integrations in the original production, Bajo el Mismo Cielo.
Source: Pharma Marketing News - Category: Pharmaceuticals Source Type: news

Related Links:

An 85-year-old woman with type 2 diabetes mellitus is admitted to the hospital due to a painful rash on her right leg. What's the next step in her care?Osmosis
Source: Medscape Med Students Headlines - Category: Universities & Medical Training Tags: Med Students Interactive Quiz Source Type: news
ConclusionsAmong the Faroese populations studied, the prevalence of type 2 diabetes increased with age and was more prevalent among men. The detected prevalence was comparable to other Nordic countries for all age-groups.
Source: Journal of Clinical and Translational Endocrinology - Category: Endocrinology Source Type: research
New research reveals that the only two medications approved for pediatric type 2 diabetes do not prevent rapid progression of prediabetes or recent onset type 2 diabetes in young people with the disease; however, analyses comparing metabolic tests of adults in a companion study and the youth study participants are helping scientists understand how the disease differs with age, which may one day lead to better treatment approaches.
Source: NIDDK News - Category: Endocrinology Source Type: news
Authors: Jansson L, Carlsson PO Abstract The pancreatic islets are more richly vascularized than the exocrine pancreas, and possess a 5- to 10-fold higher basal and stimulated blood flow, which is separately regulated. This is reflected in the vascular anatomy of the pancreas where islets have separate arterioles. There is also an insulo-acinar portal system, where numerous venules connect each islet to the acinar capillaries. Both islets and acini possess strong metabolic regulation of their blood perfusion. Of particular importance, especially in the islets, is adenosine and ATP/ADP. Basal and stimulated blood fl...
Source: Comprehensive Physiology - Category: Physiology Tags: Compr Physiol Source Type: research
Rayfield Byrd knows when it’s time to wake up every morning. The 68-year-old Oakland, Cal., resident hears a voice from the living room offering a cheery good morning. Except Byrd lives alone. A little after 8 a.m. each day, a small yellow robot named Mabu asks Byrd how he’s doing. Byrd has Type 2 diabetes and congestive heart failure, and about three years ago, he had surgery to implant a microvalve in his heart to keep his blood flowing properly. To stay healthy, he takes four medications a day and needs to exercise regularly. To make sure his heart is still pumping effectively, his doctor needs to stay on to...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized Artificial Intelligence Life Reinvented medicine Source Type: news
Conditions:   Diabetes Mellitus;   Pre Diabetes Intervention:   Dietary Supplement: Polyherbal formulation Sponsor:   Islamia University of Bahawalpur Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Novo Nordisk (NYSE:NVO) said this week that it submitted applications to the FDA for its oral formulation of semaglutide, a once-daily glucagon-like peptide-1 receptor agonist therapy. The company is hoping its pill will be approved as an adjunct to diet and exercise to improve blood sugar control in adults with Type 2 diabetes. Novo Nordisk also submitted for approval of an indication related to risk reduction of major adverse cardiovascular events. Get the full story at our sister site, Drug Delivery Business News. The post Novo Nordisk seeks FDA nod for oral diabetes pill appeared first on MassDevice.
Source: Mass Device - Category: Medical Devices Authors: Tags: Business/Financial News Diabetes Food & Drug Administration (FDA) Pharmaceuticals Regulatory/Compliance Wall Street Beat Novo Nordisk Source Type: news
Authors: Nally LM, Sherr JL, Van Name MA, Patel AD, Tamborlane WV Abstract INTRODUCTION: The expanding variety of insulins, including biosynthetic human insulin and rapid and long-acting insulin analogs, have dramatically transformed the management of type 1 diabetes (T1D) over the past 25 years. Moreover, increasing interest in the use of novel drugs developed for the treatment of type 2 diabetes (T2D) as adjunctive therapies for T1D remains a work in progress. Areas Covered: We reviewed articles published up to December 2018 in PubMed and ClinicalTrials.gov for recent developments in the pharmacologic treatment o...
Source: Expert Review of Clinical Pharmacology - Category: Drugs & Pharmacology Tags: Expert Rev Clin Pharmacol Source Type: research
THURSDAY, March 21, 2019 -- Individuals using statins may be at higher risk for hyperglycemia, insulin resistance, and eventually type 2 diabetes, according to a study published online March 5 in the British Journal of Clinical Pharmacology. Fariba...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
SUPPLEMENTS could be used to prevent or protect against diabetes type 2 symptoms and signs. You could lower your risk of high blood sugar signs by adding these cheap capsules to your daily diet.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
More News: Diabetes | Diabetes Type 2 | Endocrinology | Marketing | Pharmaceuticals